OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 10,799 shares of the conglomerate’s stock, valued at approximately $2,055,000.
A number of other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in Danaher in the 2nd quarter worth about $10,492,520,000. Norges Bank purchased a new stake in shares of Danaher during the 4th quarter worth about $2,177,106,000. Generation Investment Management LLP acquired a new stake in shares of Danaher during the 2nd quarter valued at about $1,287,949,000. Flossbach Von Storch SE acquired a new stake in shares of Danaher during the 2nd quarter valued at about $747,260,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $712,875,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Performance
Shares of NYSE DHR opened at $216.14 on Friday. The business’s 50-day simple moving average is $195.01 and its 200-day simple moving average is $192.43. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm has a market cap of $151.94 billion, a price-to-earnings ratio of 38.39, a P/E/G ratio of 2.63 and a beta of 0.78.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on the company. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Royal Bank Of Canada boosted their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Finally, TD Cowen cut their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.
Get Our Latest Stock Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
